{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:36:51Z","timestamp":1783341411241,"version":"3.54.6"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"DOI":"10.7759\/cureus.83153","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:17:04Z","timestamp":1745900224000},"source":"Crossref","is-referenced-by-count":2,"title":["Imatinib-Induced Recurrent Pleural Effusions"],"prefix":"10.7759","author":[{"given":"Pranali S","family":"Pachika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranadheer R","family":"Dande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01026-6","article-title":"The management of metastatic GIST: current standard and investigational therapeutics","volume":"14","author":"Kelly CM","year":"2021","unstructured":"Kelly CM, Gutierrez Sainz L, Chi P. The management of metastatic GIST: current standard and investigational therapeutics. J Hematol Oncol. 2021, 14:2. 10.1186\/s13045-020-01026-6","journal-title":"J Hematol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.194227","article-title":"Imatinib-induced pleural effusion: a case report","volume":"63","author":"Banka R","year":"2017","unstructured":"Banka R, Udwadia Z. Imatinib-induced pleural effusion: a case report. J Postgrad Med. 2017, 63:55-7. 10.4103\/0022-3859.194227","journal-title":"J Postgrad Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1602","article-title":"Prominent pleural effusion possibly due to imatinib mesylate in adult Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"45","author":"Ishii Y","year":"2006","unstructured":"Ishii Y, Shoji N, Kimura Y, Ohyashiki K. Prominent pleural effusion possibly due to imatinib mesylate in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Intern Med. 2006, 45:339-40. 10.2169\/internalmedicine.45.1602","journal-title":"Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.159","article-title":"Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report","volume":"10","author":"Bongiovanni A","year":"2014","unstructured":"Bongiovanni A, Ricci M, Riva N, et al.. Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report. Future Oncol. 2014, 10:2423-7. 10.2217\/fon.14.159","journal-title":"Future Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767050-00012","article-title":"Imatinib: a review of its use in the management of gastrointestinal stromal tumours","volume":"67","author":"Siddiqui MA","year":"2007","unstructured":"Siddiqui MA, Scott LJ. Imatinib: a review of its use in the management of gastrointestinal stromal tumours. Drugs. 2007, 67:805-20. 10.2165\/00003495-200767050-00012","journal-title":"Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070482","article-title":"Targeted chronic myeloid leukemia therapy: seeking a cure","volume":"64","author":"Fausel C","year":"2007","unstructured":"Fausel C. Targeted chronic myeloid leukemia therapy: seeking a cure. Am J Health Syst Pharm. 2007, 64:S9-15. 10.2146\/ajhp070482","journal-title":"Am J Health Syst Pharm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2019.0377","article-title":"Pleural effusion in adults\u2014etiology, diagnosis, and treatment","volume":"116","author":"Jany B","year":"2019","unstructured":"Jany B, Welte T. Pleural effusion in adults\u2014etiology, diagnosis, and treatment. Dtsch Arztebl Int. 2019, 116:377-86. 10.3238\/arztebl.2019.0377","journal-title":"Dtsch Arztebl Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-77-4-507","article-title":"Pleural effusions: the diagnostic separation of transudates and exudates","volume":"77","author":"Light RW","year":"1972","unstructured":"Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972, 77:507-13. 10.7326\/0003-4819-77-4-507","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2015.16.2.304","article-title":"Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management","volume":"16","author":"Kim KW","year":"2015","unstructured":"Kim KW, Shinagare AB, Krajewski KM, Pyo J, Tirumani SH, Jagannathan JP, Ramaiya NH. Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management. Korean J Radiol. 2015, 16:304-13. 10.3348\/kjr.2015.16.2.304","journal-title":"Korean J Radiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00279-2020","article-title":"Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors","volume":"56","author":"Weatherald J","year":"2020","unstructured":"Weatherald J, Bondeelle L, Chaumais MC, et al.. Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors. Eur Respir J. 2020, 56:10.1183\/13993003.00279-2020","journal-title":"Eur Respir J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.09.012","article-title":"Pleural effusion in dasatinib-treated patients with chronic myeloid leukemia in chronic phase: identification and management","volume":"17","author":"Cortes JE","year":"2017","unstructured":"Cortes JE, Jimenez CA, Mauro MJ, Geyer A, Pinilla-Ibarz J, Smith BD. Pleural effusion in dasatinib-treated patients with chronic myeloid leukemia in chronic phase: identification and management. Clin Lymphoma Myeloma Leuk. 2017, 17:78-82. 10.1016\/j.clml.2016.09.012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1517\/14740331003742935","article-title":"Pleural\/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development","volume":"9","author":"Breccia M","year":"2010","unstructured":"Breccia M, Alimena G. Pleural\/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development. Expert Opin Drug Saf. 2010, 9:713-21. 10.1517\/14740331003742935","journal-title":"Expert Opin Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24734","article-title":"Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion","volume":"116","author":"Porkka K","year":"2010","unstructured":"Porkka K, Khoury HJ, Paquette RL, Matloub Y, Sinha R, Cortes JE. Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion. Cancer. 2010, 116:377-86. 10.1002\/cncr.24734","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359792-imatinib-induced-recurrent-pleural-effusions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:17:06Z","timestamp":1745900226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359792-imatinib-induced-recurrent-pleural-effusions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.83153","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}